AAAAAA

   
Results: 1-11 |
Results: 11
LONG-TERM AND HIGH-DOSE TRIALS OF ENZYME REPLACEMENT THERAPY IN THE CANINE MODEL OF MUCOPOLYSACCHARIDOSIS
Authors: KAKKIS ED MCENTEE MF SCHMIDTCHEN A NEUFELD EF WARD DA GOMPF RE KANIA S BEDOLLA C CHIEN SL SHULL RM
Citation: Ed. Kakkis et al., LONG-TERM AND HIGH-DOSE TRIALS OF ENZYME REPLACEMENT THERAPY IN THE CANINE MODEL OF MUCOPOLYSACCHARIDOSIS, Biochemical and molecular medicine, 58(2), 1996, pp. 156-167
MYOBLAST GENE-THERAPY IN CANINE MUCOPOLYSACCHARIDOSIS-I - ABROGATION BY AN IMMUNE-RESPONSE TO ALPHA-L-IDURONIDASE
Authors: SHULL RM LU XC MCENTEE MF BRIGHT RM PEPPER KA KOHN DB
Citation: Rm. Shull et al., MYOBLAST GENE-THERAPY IN CANINE MUCOPOLYSACCHARIDOSIS-I - ABROGATION BY AN IMMUNE-RESPONSE TO ALPHA-L-IDURONIDASE, Human gene therapy, 7(13), 1996, pp. 1595-1603
INTRATHYMIC ANTIGEN INJECTION AND IMMUNO-SUPPRESSIVE DRUG-THERAPY FAIL TO PREVENT AN IMMUNE-RESPONSE FOLLOWING GENE-THERAPY IN CANINE MPS-I
Authors: LU X MCENTEE MF BRIGHT RM SHULL RM
Citation: X. Lu et al., INTRATHYMIC ANTIGEN INJECTION AND IMMUNO-SUPPRESSIVE DRUG-THERAPY FAIL TO PREVENT AN IMMUNE-RESPONSE FOLLOWING GENE-THERAPY IN CANINE MPS-I, Blood, 88(10), 1996, pp. 3922-3922
PHENOTYPIC IMPROVEMENT OF MACROPHAGES IN LYMPH-NODES FROM DOGS WITH MUCOPOLYSACCHARIDOSIS-I AFTER IN-VIVO GENE DELIVERY TO MUSCLE
Authors: PODSAKOFF GM LU X MCENTEE MF HUANG MM KURTZMAN GJ KOHN DB SHULL RM
Citation: Gm. Podsakoff et al., PHENOTYPIC IMPROVEMENT OF MACROPHAGES IN LYMPH-NODES FROM DOGS WITH MUCOPOLYSACCHARIDOSIS-I AFTER IN-VIVO GENE DELIVERY TO MUSCLE, Blood, 88(10), 1996, pp. 1067-1067
GENE-THERAPY TOWARD HURLERS SYNDROME
Authors: HUANG MM KAKKIS E SHULL RM NEUFELD EF KOHN DB
Citation: Mm. Huang et al., GENE-THERAPY TOWARD HURLERS SYNDROME, Journal of cellular biochemistry, 1995, pp. 366-366
LONG-TERM ENZYME REPLACEMENT THERAPY OF CANINE MUCOPOLYSACCHARIDOSIS
Authors: KAKKIS ED SHULL RM MCENTEE MF SCHMIDTCHEN A NEUFELD E
Citation: Ed. Kakkis et al., LONG-TERM ENZYME REPLACEMENT THERAPY OF CANINE MUCOPOLYSACCHARIDOSIS, Pediatric research, 37(4), 1995, pp. 149-149
LONG-TERM AND HIGH-DOSE ENZYME REPLACEMENT THERAPY IN THE CANINE MUCOPOLYSACCHARIDOSIS-I MODEL
Authors: KAKKIS ED SHULL RM MCENTEE MF SCHMIDTCHEN A NEUFELD EF
Citation: Ed. Kakkis et al., LONG-TERM AND HIGH-DOSE ENZYME REPLACEMENT THERAPY IN THE CANINE MUCOPOLYSACCHARIDOSIS-I MODEL, American journal of human genetics, 57(4), 1995, pp. 193-193
TREATMENT OF CANINE MPS-I WITH RECOMBINANT HUMAN ALPHA-L-IDURONIDASE
Authors: KAKKIS ED SHULL RM MISHU L CHIEN SL JONAS AJ NEUFELD EF
Citation: Ed. Kakkis et al., TREATMENT OF CANINE MPS-I WITH RECOMBINANT HUMAN ALPHA-L-IDURONIDASE, Pediatric research, 35(4), 1994, pp. 10000152-10000152
ENZYME REPLACEMENT IN A CANINE MODEL OF HURLER-SYNDROME
Authors: SHULL RM KAKKIS ED MCENTEE MF KANIA SA JONAS AJ NEUFELD EF
Citation: Rm. Shull et al., ENZYME REPLACEMENT IN A CANINE MODEL OF HURLER-SYNDROME, Proceedings of the National Academy of Sciences of the United Statesof America, 91(26), 1994, pp. 12937-12941
TREATMENT OF CANINE MPS 1 USING RECOMBINANT ALPHA-L-IDURONIDASE
Authors: KAKKIS ED JONAS AJ SHULL RM MISHU L NEUFELD EF
Citation: Ed. Kakkis et al., TREATMENT OF CANINE MPS 1 USING RECOMBINANT ALPHA-L-IDURONIDASE, American journal of human genetics, 53(3), 1993, pp. 102-102
CLONING AND CHARACTERIZATION OF CDNA-ENCODING CANINE ALPHA-L-IDURONIDASE - MESSENGER-RNA DEFICIENCY IN MUCOPOLYSACCHARIDOSIS-I DOG
Authors: STOLTZFUS LJ SOSAPINEDA B MOSKOWITZ SM MENON KP DLOTT B HOOPER L TEPLOW DB SHULL RM NEUFELD EF
Citation: Lj. Stoltzfus et al., CLONING AND CHARACTERIZATION OF CDNA-ENCODING CANINE ALPHA-L-IDURONIDASE - MESSENGER-RNA DEFICIENCY IN MUCOPOLYSACCHARIDOSIS-I DOG, The Journal of biological chemistry, 267(10), 1992, pp. 6570-6575
Risultati: 1-11 |